Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Puggina

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Public Health|September 16, 2015
Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature reviewAnna Puggina, Athanasios Broumas, Walter Ricciardi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young AdultsFernando Matias Gonzalez, Maria Assunta Veneziano, Anna Puggina, et al.
Vaccines|April 23, 2025
The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Expert Review of Vaccines|February 3, 2026
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Open Forum Infectious Diseases|February 23, 2019
The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in ItalySean Matthews, Antonio De Maria, Marco Passamonti, et al.
Clinical Drug Investigation|September 13, 2017
Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and TreatmentGabriella Ferrandina, Giulia Amadio, Andrea Marcellusi, et al.
Human Vaccines & Immunotherapeutics|August 24, 2019
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in ItalyAntonio Volpi, Sara Boccalini, Silvia Dari, et al.
Diseases (Basel, Switzerland)|March 26, 2025
Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged ≥ 60 Years: A Retrospective Cohort StudyAnna Puggina, Melania Dovizio, Alexander Domnich, et al.
Human Vaccines & Immunotherapeutics|March 24, 2025
Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort studyAnna Puggina, Melania Dovizio, Alexander Domnich, et al.
Plos One|August 28, 2025
Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and ItalyAnna Puggina, Alen Marijam, Olivier Cailloux, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Public Health|September 16, 2015
Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature reviewAnna Puggina, Athanasios Broumas, Walter Ricciardi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young AdultsFernando Matias Gonzalez, Maria Assunta Veneziano, Anna Puggina, et al.
Vaccines|April 23, 2025
The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Expert Review of Vaccines|February 3, 2026
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Open Forum Infectious Diseases|February 23, 2019
The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in ItalySean Matthews, Antonio De Maria, Marco Passamonti, et al.
Clinical Drug Investigation|September 13, 2017
Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and TreatmentGabriella Ferrandina, Giulia Amadio, Andrea Marcellusi, et al.
Human Vaccines & Immunotherapeutics|August 24, 2019
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in ItalyAntonio Volpi, Sara Boccalini, Silvia Dari, et al.
Diseases (Basel, Switzerland)|March 26, 2025
Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged ≥ 60 Years: A Retrospective Cohort StudyAnna Puggina, Melania Dovizio, Alexander Domnich, et al.
Human Vaccines & Immunotherapeutics|March 24, 2025
Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort studyAnna Puggina, Melania Dovizio, Alexander Domnich, et al.
Plos One|August 28, 2025
Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and ItalyAnna Puggina, Alen Marijam, Olivier Cailloux, et al.
Pageof 3